IDDI starts Research on Statistical Method for individualization of Therapy
Published on:
Applied Clinical Trials
Clinical services provider International Drug Development Institute (IDDI) is forming a research collaborative into the use of a new statistical method called Generalized Pairwise Comparisons (GPC). The objective of the collaborative is to establish proof of the concept that the GPC method can complement traditional methods for the design, analysis and interpretation of clinical trial results in regard to accounting for multiple endpoints at once and ranked in order of priority. In addition to IDDI’s lead, the collaborative includes Bristol-Myers Squibb, the European Organization for Research and Treatment of Cancer (EORTC), the Université Catholique de Louvain and the University Hospital and Cancer Center of Lyon.
